General Atlantic is exploring the sale of OneOncology, an operator of independent cancer-care practices, according to people with knowledge of the matter, reports Bloomberg.
The growth equity-focused investment firm, which has backed OneOncology since 2018, is working with an adviser to solicit interest in the Nashville, Tennessee-based company, which could fetch more than $2 billion including debt in a sale, said the people, who asked not to be identified discussing confidential information. Read more.
